On Monday, Wall Street financial analysts revised their ratings and price targets for several US-listed companies, including Exxon Mobil, Northrop Grumman, and Regeneron Pharmaceuticals.
Highlights:
– Chevron (CVX.N): HSBC raises price target from $217 to $221. – Exxon Mobil Corporation (XOM.N): HSBC raises price target from $158 to $168. – Northrop Grumman (NOC.N): Bernstein lowers price target from $765 to $660. – Walmart Inc (WMT.O): Jefferies raises price target from $145 to $150. – Regeneron Pharmaceuticals Inc (REGN.O): Piper Sandler lowers price target from $875 to $855.
Here is a summary of research recommendations on US companies published by Reuters on Monday. The titles are listed alphabetically.
– Ball Corp (BALL.N): JP Morgan upgrades from “neutral” to “overweight.” – Blue Owl Technology Finance Corp (OTF.N): RBC lowers price target from $14 to $12. – BP (BP.N): Gerdes Energy Research upgrades from “neutral” to “buy.” – Chevron (CVX.N): HSBC raises price target from $217 to $221. – Crown Holdings Inc (CCK.N): JP Morgan upgrades from “neutral” to “overweight.” – Dollar General Corp (DG.N): Jefferies lowers price target from $170 to $155. – Dollar Tree Inc (DLTR.O): Jefferies lowers price target from $80 to $75. – Echostar Corp (SATS.O): TD Cowen raises price target from $129 to $155. – Elf Beauty Inc (ELF.N): Canaccord Genuity lowers price target from $121 to $100. – Exxon Mobil Corporation (XOM.N): HSBC raises price target from $158 to $168. – Hamilton Lane Inc (HLNE.O): JP Morgan lowers price target from $166 to $148. – Kodiak Gas Services Inc (KGS.N): RBC raises price target from $64 to $84. – National Healthcare Properties (NHP.O): RBC rates as “sector perform” with $15 price target. – Northrop Grumman (NOC.N): Bernstein lowers price target from $765 to $660. – Outokumpu (OUT1V.HE): Alphavalue upgrades from “sell” to “buy.” – Regeneron Pharmaceuticals Inc (REGN.O): Jefferies lowers price target from $890 to $870. – Regeneron Pharmaceuticals Inc (REGN.O): JP Morgan lowers price target from $950 to $850. – Regeneron Pharmaceuticals Inc (REGN.O): Piper Sandler lowers price target from $875 to $855. – Regeneron Pharmaceuticals Inc (REGN.O): RBC lowers price target from $762 to $707. – Sutro Biopharma Inc (STRO.O): Piper Sandler raises price target from $29 to $61. – Uber (UBER.N): Zephirin Group lowers price target from $86 to $81. – Walmart Inc (WMT.O): Jefferies raises price target from $145 to $150. – Westlake Corp (WLK.N): JP Morgan upgrades from “underweight” to “neutral.” – Williams-Sonoma Inc (WSM.N): RBC lowers price target from $213 to $191. – Yesway Inc (YSWY.O): JP Morgan initiates coverage with “neutral” rating and $29 price target. – York Space Systems Inc (YSS.N): Raymond James lowers price target from $55 to $45.
